|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 209/12 | (2006.01) |
| A61P 9/12 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 1717226 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06117363.9 |
| Date of filing the European patent application | 2005-03-17 | |
| (97) | Date of publication of the European application | 2006-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2009-01-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 20040046904 | 2004-03-19 | CH |
| (72) |
Herold, Peter, CH
Stutz, Stefan, CH
Mah, Robert, CH
Tschinke, Vincenzo, CH
Stojanovic, Aleksandar, CH
Jotterand, Nathalie, CH
Quirmbach, Michael, CH
Behnke, Dirk, DE
Marti, Christiane, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTAN AMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION |
| 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTAN AMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION |